Digital Pathology Global Market Report 2024

The digital pathology market size has grown rapidly in recent years. It will grow from $1.07 billion in 2023 to $1.26 billion in 2024 at a compound annual growth rate (CAGR) of 17.6%. The historic growth in the digital pathology market was influenced by factors such as the rapid expansion of the elderly population, a rise in medical errors, increased prevalence of cancer and chronic diseases, growth in healthcare facilities, higher healthcare expenditure, reforms in public health insurance, and the impact of the COVID-19 pandemic.

The digital pathology market size is expected to see rapid growth in the next few years. It will grow to $2.41 billion in 2028 at a compound annual growth rate (CAGR) of 17.8%. The forecasted growth in the digital pathology market is driven by factors such as government support, increased adoption of digital devices, rising prevalence of cancer and chronic diseases, an aging population, and the emergence of infectious diseases. Key trends include the use of artificial intelligence, cloud technology, adoption of digital imaging, development of new technological solutions, strategic partnerships, and increased investment in research and development activities.

The increased incidence of cancer has significantly contributed to the expansion of the digital pathology market. Digital pathology plays a crucial role in expediting the diagnosis and treatment of cancer, and the rising number of cancer cases is a key driver of market growth. As of January 2023, the American Cancer Society, a nonprofit cancer advocacy organization based in the United States, reported a 3.16% increase in the number of cancer cases, rising from 1,898,160 in 2021 to 1,958,310. This surge in cancer incidences fuels the demand for digital pathology, enabling quicker access to images, comprehensive information viewing, and faster diagnoses.

The digital pathology market is anticipated to receive support from the emergence of infectious diseases and novel pathogenic infestations. Outbreaks of diseases such as SARS, Zika virus, Ebola, and COVID-19 have led to increased infections worldwide, elevating the global disease burden. Digital pathology facilitates real-time consultation for pathologic diagnosis in suspected cases of infectious diseases, enabling professionals such as pathologists and laboratorians to collaborate effectively. Zoonotic infectious agents, which are diseases that originate in animals and evolve to infect humans, account for about 60% of known human pathogens and up to 75% of emerging human pathogens. Climate change is expected to alter the epidemiology of infectious diseases by influencing the geographic ranges of microbes and vectors. As microbes adapt to higher temperatures, concerns arise about the selection of heat-tolerant microbes that can overcome human defenses, leading to new infectious diseases and altering the epidemiology of existing diseases. This dynamic scenario fuels the demand for digital pathology, supporting market growth.

The shortage of trained pathologists posed a challenge to the digital pathology market in the historical period. Pathologists play a crucial role in conducting essential laboratory tests for disease diagnosis, involving the examination and interpretation of medical laboratory samples. The Asia-Pacific region and several African countries face a scarcity of pathologists, impacting the timely examination of medical samples. For instance, in February 2022, a forensic magazine report highlighted a backlog of 217 bodies awaiting examination by state forensic pathologists, with projections of the figure rising to 300 in less than two weeks. Additionally, more than 200 bodies were awaiting autopsies, emphasizing the strain on pathologist resources.

Artificial intelligence (AI) stands out as a prominent trend gaining traction in the digital pathology market. Healthcare companies leverage AI to enhance the automation of various operational processes. AI algorithms, utilizing image classification, contribute to the detection of features associated with human diseases, such as cancer cells, and agricultural issues such as leaf coloring and decay. In January 2022, Inform Diagnostics, a US-based pathology lab, introduced the Paige FullFocus digital pathology viewer in its laboratories. This adoption of new technology empowers pathologists at Inform Diagnostics to leverage AI tools, streamline logistics, and achieve faster turnaround times for results.

In March 2022, SourceBio International PLC, a UK-based provider of integrated laboratory services and products, successfully completed the acquisition of LDPath Ltd for an initial amount of £18.5 million ($19.76 million). The company is strategically planning a share buyback, utilizing the funds generated from its Covid PCR testing services over the preceding two years. This acquisition enhances SourceBio International's position, aiming to become the leading outsourced partner for delivering cellular pathology testing to NHS trusts and private healthcare providers in the UK. The expanded group has set its sights on converting both NHS and private clients to embrace digital pathology services. LDPath Ltd is a UK-based provider specializing in digital pathology testing services.

Major companies operating in the digital pathology market report are Danaher Corporation, Hoffmann-La Roche Ltd., Koninklijke Philips N.V, Hamamatsu Photonics K.K, 3DHISTECH Ltd., Olympus Corporation, Nikon Corporation, Visiopharm A/S, Indica Labs Inc., Sectra AB, Grundium, Leica Biosystems, Apollo Enterprise Imaging Corp, Inspirata Inc., PathAI, Aiforia Technologies, Proscia, Ibex Medical Analytics, Better Doc, Biovotion, BrainControl, Coimbra Genomics, Dacadoo, Doctoralia, Emperra, Exovite, Genexyx, Giraff, Healthbank, NeurNation, Nutrino, Psious, Px Healthcare, SilverCloud, Systems Healthcare Solutions, TrialReach, XtremeVRI, Ventana Medical Systems, Huron Digital Pathology, Synevo, Gero AI, TeleMD, mediSensum, Apteki +, ECG for Everybody, Paige.AI, Morphle, Akoya, Aperio Digital Pathology, Smart in Media, MaRS, Perkin Elmer, Definiens AG, Digipath, Nuclei, Aspen Medical, Ensign Medical Coding, Al Talouk Medical Coding Training, WCM-Q, Response Plus Holding, Health-Tech Training, CAE, Medical-X, C3? Holter Monitor, BIOEGYPT, Pulse.

North America was the largest region in the digital pathology market in 2023. Asia-Pacific was the second largest region in the digital pathology market. The regions covered in the digital pathology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital pathology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Key products in digital pathology include scanners, software, communication systems, and storage systems. Scanners utilize microscopic array technology to create three-dimensional digital representations of pathology slides for viewing and automated image analysis. Software aids in transferring data to digital formats for image review, analysis, and tissue image analysis. Communication systems facilitate interaction between various components for slide acquisition, storage, viewing, and real-time telepathology with remote colleagues. Storage systems involve digital archives for long-term sample analysis and predictive analytics. Pathology branches into human pathology and veterinary pathology. Digital pathology finds application across pharmaceutical & biotechnology companies, hospitals, reference laboratories, academic & research institutes. Its uses encompass drug discovery, disease diagnosis, teleconsultation, and training & education purposes.

The digital pathology market research report is one of a series of new reports that provides digital pathology market statistics, including digital pathology industry global market size, regional shares, competitors with a digital pathology market share, detailed digital pathology market segments, market trends and opportunities, and any further data you may need to thrive in the digital pathology industry. This digital pathology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital pathology market consists of the sales of slide scanners, software, and reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.


The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.